The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.
Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by ...
Hordes of brilliant, graduate-degree-holding professionals in their 40s, 50s, and beyond act helpless at work,” writes STAT ...
Just 40 percent of Americans reported a lot of confidence in U.S. hospitals and health clinics, the same proportion as in ...
Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for ...
The AHA is once again suing the Trump administration over its plan to revamp a federal drug discount program into one that ...
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to rising ...
The federal government has released new quality ratings for Medicare Advantage insurers for 2027, with Humana emerging as the ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Want to stay on top of the science and ...
The Trump administration wants to make three big changes to the U.S. Census, including eliminating questions about race, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results